NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT00004930 2013-06-19Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung MetastasesMemorial Sloan Kettering Cancer CenterPhase 1 Completed
NCT00020124 2012-03-15Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the LungsNational Institutes of Health Clinical Center (CC)Phase 1 Completed